OncoLink Cancer Treatment and Resources

Great Debates and Updates in Breast Cancer



Imedex, LLC
Last Modified: February 13, 2009

Conference Dates: June 19-20, 2009
Conference Location: San Francisco, CA

Sponsoring Group: Imedex, LLC

Conference Web Page URL: www.imedex.com/appweb/announcements/A048-01.asp

Topics Covered:

  • Chemoprevention of breast cancer
  • Selecting techniques for breast cancer surgery
  • Confusion and controversies in radiation therapy
  • Integration of bisphosphonates into adjuvant therapy regimens for early breast cancer
  • Clinical updates in translational science
  • Interpretation and integration of recent clinical trial data into clinical practice
  • Pharmacogenomics and effects on drug interactions, efficacy and safety
  • Combinations of hormonal and biologic agents
  • Appropriate use of anthracyclines in early breast cancer
  • Treatment of pre- and-postmenopausal women with hormone receptor-positive breast cancer
  • Management of patients with relapsed HER2-positive breast cancer
  • Potential role for EGFR targeted therapy in breast cancer
  • Novel cytotoxic agents for breast cancer
  • Management of triple negative/basal type breast cancer
  • Monitoring and managing the cardiotoxicity of systemic therapeutic agents
  • Optimal use of lapatinib in patients with HER2-positive metastatic breast cancer
  • Mechanisms and management of trastuzumab resistance

Conference Objectives: Great Debates and Updates in Breast Cancer will be a world class medical education forum for the exchange of critical information in the field of breast cancer. It features didactic presentations and a debate format, in which distinguished faculty discuss some of the most challenging topics in breast cancer.

Who Should Attend: Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Nurses, Fellows, and Residents.

Conference Agenda: www.imedex.com/appweb/announcements/a048-01.asp

Registration Information: To pre-register, registration and payment must be received no later than June 11, 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure that the program is being held as scheduled and to confirm that the meeting is not full.

Conference Fees: $75 - $150

Continuing Education: Yes

OncoLink I wish u knew...

Ms. Bruning talks about working in development for a cancer center and how this translates to hope in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS